View in EDS

Podocyte-directed VEGFC gene therapy prevents increased glomerular permeability and glycocalyx damage in experimental type 1 diabetes.

Saved in:
Bibliographic Details
Title: Podocyte-directed VEGFC gene therapy prevents increased glomerular permeability and glycocalyx damage in experimental type 1 diabetes.
Authors: Martin Alonso A; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK., May CJ; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK., Stowell-Connolly H; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK., Wu H; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK., Gamez M; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK., Ourradi K; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK., Ramnath RD; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK., Ding WY; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK., Welsh GI; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK., Satchell SC; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK., Foster RR; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK. Electronic address: becky.foster@bristol.ac.uk.
Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2026 Jan 07; Vol. 34 (1), pp. 117-122. Date of Electronic Publication: 2025 Oct 06.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41058176
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Podocyte-directed VEGFC gene therapy prevents increased glomerular permeability and glycocalyx damage in experimental type 1 diabetes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martin+Alonso+A%22">Martin Alonso A</searchLink>; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK.<br /><searchLink fieldCode="AU" term="%22May+CJ%22">May CJ</searchLink>; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK.<br /><searchLink fieldCode="AU" term="%22Stowell-Connolly+H%22">Stowell-Connolly H</searchLink>; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK.<br /><searchLink fieldCode="AU" term="%22Wu+H%22">Wu H</searchLink>; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK.<br /><searchLink fieldCode="AU" term="%22Gamez+M%22">Gamez M</searchLink>; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK.<br /><searchLink fieldCode="AU" term="%22Ourradi+K%22">Ourradi K</searchLink>; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK.<br /><searchLink fieldCode="AU" term="%22Ramnath+RD%22">Ramnath RD</searchLink>; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK.<br /><searchLink fieldCode="AU" term="%22Ding+WY%22">Ding WY</searchLink>; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK.<br /><searchLink fieldCode="AU" term="%22Welsh+GI%22">Welsh GI</searchLink>; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK.<br /><searchLink fieldCode="AU" term="%22Satchell+SC%22">Satchell SC</searchLink>; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK.<br /><searchLink fieldCode="AU" term="%22Foster+RR%22">Foster RR</searchLink>; Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS1 3NY, UK. Electronic address: becky.foster@bristol.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100890581%22">Molecular therapy : the journal of the American Society of Gene Therapy</searchLink> [Mol Ther] 2026 Jan 07; Vol. 34 (1), pp. 117-122. <i>Date of Electronic Publication: </i>2025 Oct 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100890581 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1525-0024 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215250016%22">15250016 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41058176
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ymthe.2025.10.001
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 117
    Titles:
      – TitleFull: Podocyte-directed VEGFC gene therapy prevents increased glomerular permeability and glycocalyx damage in experimental type 1 diabetes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martin Alonso A
      – PersonEntity:
          Name:
            NameFull: May CJ
      – PersonEntity:
          Name:
            NameFull: Stowell-Connolly H
      – PersonEntity:
          Name:
            NameFull: Wu H
      – PersonEntity:
          Name:
            NameFull: Gamez M
      – PersonEntity:
          Name:
            NameFull: Ourradi K
      – PersonEntity:
          Name:
            NameFull: Ramnath RD
      – PersonEntity:
          Name:
            NameFull: Ding WY
      – PersonEntity:
          Name:
            NameFull: Welsh GI
      – PersonEntity:
          Name:
            NameFull: Satchell SC
      – PersonEntity:
          Name:
            NameFull: Foster RR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 01
              Text: 2026 Jan 07
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1525-0024
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular therapy : the journal of the American Society of Gene Therapy
              Type: main
ResultId 1